Status:
COMPLETED
Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study.
Lead Sponsor:
Zagazig University
Conditions:
Pancreas Cancer
Eligibility:
All Genders
Brief Summary
Introduction: Pancreatic cystic neoplasms (PCNs) comprise neoplasms with a wide range of benign and malignant varieties. The most common include serous cystic neoplasms (SCNs), mucinous cystic neoplas...
Detailed Description
Introduction: Pancreatic cystic neoplasms (PCNs) comprise neoplasms with a wide range of benign and malignant varieties. The most common include serous cystic neoplasms (SCNs), mucinous cystic neoplas...
Eligibility Criteria
Inclusion
- any Age
- both sex,
- expected R0 resection,
- Tumor of any size,
- no previous pancreatic surgery with diagnosis of True exocrine pancreatic cystic neoplasms
Exclusion
- endocrinal pancreatic tumors,
- solid pancreatic tumors,
- previous pancreatic surgery,
- recurrent pancreatic tumor,
- Combined operation,
- prior history of any malignancy and misdiagnosed cases discovered on postoperative pathological cases as pancreatic pseudo-cyst or endocrine tumors
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04747600
Start Date
June 1 2014
End Date
January 1 2021
Last Update
October 10 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.